36
https://pubmed.ncbi.nlm.nih.gov/38112032
In patients with Alzheimer’s disease, carrying the APOE ε4 allele is associated with cognitive impairment, decreased nerve growth factor (NGF) levels in cerebrospinal fluid, and NGF mediates APOE ε4-associated cognitive impairment.